INTU and non-small cell lung carcinoma: Zhou et al. found that integrin β3 (β3-int) is highly upregulated in NSCLC patients with spinal metastasis (NSCLC-SM), and the inhibition of β3-int would lead to the ubiquitin degradation of PD-L1.